These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 8405061

  • 21. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.
    Wolpert EZ, Grufman P, Sandberg JK, Tegnesjö A, Kärre K.
    J Immunol; 1998 Nov 01; 161(9):4499-505. PubMed ID: 9794374
    [Abstract] [Full Text] [Related]

  • 22. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y, Mayumi H, Eto M, Nomoto K.
    J Immunol; 1990 Mar 15; 144(6):2425-35. PubMed ID: 1968930
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.
    Forquet F, Calin V, Trescol-Biemont MC, Kanellopoulos J, Mottez E, Kourilsky P, Rabourdin-Combe C, Gerlier D.
    Eur J Immunol; 1990 Oct 15; 20(10):2325-32. PubMed ID: 2242761
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A, Schirmbeck R, Reimann J.
    Eur J Immunol; 1994 May 15; 24(5):1172-80. PubMed ID: 7514132
    [Abstract] [Full Text] [Related]

  • 29. Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses.
    Speidel K, Osen W, Faath S, Hilgert I, Obst R, Braspenning J, Momburg F, Hämmerling GJ, Rammensee HG.
    Eur J Immunol; 1997 Sep 15; 27(9):2391-9. PubMed ID: 9341785
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR.
    J Immunol; 1984 May 15; 132(5):2665-71. PubMed ID: 6425410
    [Abstract] [Full Text] [Related]

  • 32. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
    Schirmbeck R, Böhm W, Reimann J.
    J Immunol; 1996 Oct 15; 157(8):3550-8. PubMed ID: 8871655
    [Abstract] [Full Text] [Related]

  • 33. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun 15; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides.
    Bertholet S, Iggo R, Corradin G.
    Eur J Immunol; 1997 Mar 15; 27(3):798-801. PubMed ID: 9079825
    [Abstract] [Full Text] [Related]

  • 35. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
    de Waal LP, de Hoop J, Stukart MJ, Gleichmann H, Melvold RW, Melief CJ.
    J Immunol; 1983 Feb 15; 130(2):655-60. PubMed ID: 6401303
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides.
    Wolpert E, Franksson L, Kärre K.
    Int Immunol; 1995 Jun 15; 7(6):919-28. PubMed ID: 7577800
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunodominant minor histocompatibility antigen peptides presented by H2Db molecules.
    Nevala WK, Wettstein PJ.
    Transplantation; 1997 Nov 15; 64(9):1323-30. PubMed ID: 9371675
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.